Home » Topics » Regulatory » Patents

Patents
RSS

Aurigene Discovery Technologies patents PD-1 signaling inhibitors

Sep. 22, 2016

Amgen describes Nav1.7 channel blockers

Sep. 21, 2016

Danish scientists disclose DNA gyrase and topoisomerase IV inhibitors

Sep. 21, 2016

Prozymex patents DPPI inhibitors

Sep. 21, 2016

Bristol-Myers Squibb and Rigel Pharmaceuticals describe TGF-beta1 inhibitors

Sep. 20, 2016

Eli Lilly discloses GPR142 agonists

Sep. 20, 2016

Shanghai Institute Materia Medica patents anticancer agents

Sep. 20, 2016

Nitto Denko patents carboxylesterase inhibitors

Sep. 16, 2016

Bristol-Myers Squibb reports development of NS5B inhibitors

Sep. 13, 2016

Bayer Pharma describes anticancer agents

Sep. 13, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026